Video Interview: Smart for Life (SMFL) CEO A.J. Cervantes.

Excellent interview. We were at the Noble Investor Conference to see it live. And we were at the manufacturing plant this Friday....

Smart For Life to Present at The Noble Capital Markets Eighteenth Annual Investor Conference.

MIAMI, April 14, 2022 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leading...

Billion Dollar Aggregators Buying Mom-and-Pop Amazon Sellers. Simply Amazing.

At least 77 Amazon aggregators have raised roughly $10 billion in total since April 2020, according to Marketplace Pulse.
Dalrada, Biotech Stock Review

Dalrada (DFCO) Announces Form S-1 Registration Declared Effective by SEC

SAN DIEGO , Nov. 3, 2020 /PRNewswire/ -- Dalrada Financial Corp. (OTC Pink: DFCO), is pleased to announce that its Form S-1 registration statement has been declared...
Hapbee, Biotech Stock Review

Telehealth App Hapbee (HAPB) Goes Public and More.

1. Hapbee (HAPB) $0.30, Going Public.2. Saying Goodbye to Immunomedics (IMMU) $86.3. Adding Biosig (BSGM) $2.95, to Watch...

Healthcare and Technology Incubator Dalrada (DFCO) Bolsters LikidoONE’s® Clean Technology.

LikidoONE® 'HFC Free' Heat and Refrigeration pump, already a model marvel of engineering technology, anticipates an additional 12% boost in energy cost-cost...

True Nature|Mitesco (TNTY). Coverage Report Issued.

Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
True Nature, Mitesco, Biotech Stock Review

True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.

Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
True Nature, Biotech Stock Review

True Nature | Mitesco (TNTY), Perking Up.

Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...

Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...

We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...

Latest article

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we...

Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.

DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!